Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Endocrine|September 4, 2024
An update on redifferentiation strategies for radioactive iodine-refractory differentiated thyroid carcinomaTheodora Pappa, Lori Wirth
Expert Opinion on Emerging Drugs|August 31, 2006
Emerging drugs for head and neck cancerRobert Haddad, Lori Wirth, Marshall Posner
Expert Review of Anticancer Therapy|June 25, 2003
Integration of chemotherapy in the curative treatment of locally advanced head and neck cancerRobert I Haddad, Lori Wirth, Marshall R Posner
Seminars in Oncology|January 17, 2004
Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neckRobert Haddad, Lori Wirth, Rosemary Costello, et al.
Expert Review of Endocrinology & Metabolism|February 21, 2019
Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directionsFurio Pacini, Yasuhiro Ito, Markus Luster, et al.
NPJ Precision Oncology|October 9, 2022
Single-cell transcriptomic profiling for inferring tumor origin and mechanisms of therapeutic resistanceMaoxuan Lin, Moshe Sade-Feldman, Lori Wirth, et al.
JCO Precision Oncology|January 27, 2025
Correlates of Cetuximab Efficacy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Previously Treated With ImmunotherapyJong Chul Park, Jong Seok Ahn, Ross Merkin, et al.
Oral Oncology|March 20, 2024
Immunotherapy time of infusion impacts survival in head and neck cancer: A propensity score matched analysisDaniel A Ruiz-Torres, Saskia Naegele, Archana Podury, et al.
Archives of Otolaryngology--Head & Neck Surgery|June 21, 2006
Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neckRobert Haddad, Roy Tishler, Lori Wirth, et al.
Oral Oncology|December 16, 2004
Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neckAbhay S Gokhale, Robert I Haddad, Lisa A Cavacini, et al.
Pageof 4